Dottikon ES Holding AG (SWX:DESN)

Revenue by Segment

Financials in millions CHF. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Chemicals, Intermediates, and Exclusive Active Pharmaceutical Ingredients (API)	439.92M	392.68M	332.98M	325.88M	251.93M
Chemicals, Intermediates, and Exclusive Active Pharmaceutical Ingredients (API) Growth	12.03%	17.93%	2.18%	29.35%	15.09%
Total	439.92M	392.68M	332.98M	325.88M	251.93M
Total Growth	12.03%	17.93%	2.18%	29.35%	15.09%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jun 20, 2026

Data Sources Report a data error